S&P DJ Indices Announces March Quarterly Review
Filed with ASX · · 9 pages · English
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings CallMedical Developments International Limited on 6ix
Story so far
Earlier from Medical Developments International
- S&P DJ Indices Announces March Quarterly Rebalance
- MVP signs major deal with CSIRO
- MVP signs Licensing Agreement for Penthrox in Canda
- Penthrox receives regulatory approval in the UAE
- Licensing deal for Korea
Later from Medical Developments International
- POST TRUMP - Business as usual, MVP signs a Respiratory deal
- Penthrox submitted for approval in 22 European Countries
- Penthrox approved for sale in Taiwan
- Penthrox European Update
- Penthrox Launched in France and Belgium and first sales
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International